Do New pN Subclassifications Proposed by IASLC’s Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?-Reference-Cited by-同舟云学术

Do New pN Subclassifications Proposed by IASLC’s Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?

Published:2016-12 Issue:12 Volume:11 Page:2202-2207
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Kim Hakyoung,Ahn Yong Chan,Pyo Hongryull,Oh Dongryul,Noh Jae Myoung,Sun Jong-Mu,Ahn Jin Seok,Ahn Myung-Ju,Park Keunchil,Choi Yong Soo,Kim Jhingook,Zo Jae Ill,Shim Young Mog,Lee Minju,Han Jungho

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference9 articles.

1. The International Association for the Study of Lung Cancer Lung Cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer;Asamura;J Thorac Oncol,2015

2. Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer;Hyun;Eur J Nucl Med Mol Imaging,2014

3. Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer;Kang;J Korean Med Sci,2006

4. Analyses on prognostic factors following tri-modality therapy for stage IIIa non-small cell lung cancer;Kim;Lung Cancer,2007

5. Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapy;Lee;Ann Surg Oncol,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Skip vs. Non-Skip N2 Lymph Node Metastasis on the Prognosis of Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis;Frontiers in Surgery;2021-10-12

2. Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non–small-cell Lung Cancer: A Propensity Score Matching Analysis;Clinical Lung Cancer;2019-05